<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_XJTLU-CHINA_Modelling1 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:XJTLU-CHINA/Modelling1</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container"><NAV class="navbar navbar-default navbar-fixed-top" style="box-shadow: 1px 2px 4px rgba(43,43,43,0.5); margin-bottom: 0px"><DIV class="container-fluid"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav"><LI style="margin-left: 100px"><A href="https://2018.igem.org/Team:XJTLU-CHINA">Home</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Exosome_Biogenesis">Exosome Biogenesis</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/RNA_Packaging">RNA Packaging</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Targeting_And_Delivery">Targeting and Delivery</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/RNA_Stabilization">RNA Stabilization</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Demonstrate">Results</A></LI></UL><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Modeling </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Model">Our Model</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Modelling1">Pharmacokinetic model</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Modelling2">mRNA delivery simulation</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Modelling3">Functional exosome production system</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Human Practice</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/HP/Silver">Silver</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/HP/Gold">Gold</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Education">Education</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Collaborations">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Survey_And_Policy">Survey and Policy</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Notebook </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Labbook">Lab Book</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Protocols">Protocols</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Parts </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Basic_Part">Basic Parts</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Composite_Part">Composite Parts</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Team </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Team">Members</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Attributions">Attribution</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Safety">Safety</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/InterLab">InterLab</A></LI></DIV></DIV></NAV></DIV><DIV class="container-fluid" style="background-color: rgb(84,146,197); padding: 40px 30px; margin-top: 35px"><H1 style="font-family:'Impact'; color: white; font-size: 80px; margin-top: 20px; margin-bottom: 50px; float: left; margin-left: 20px">
        Pharmacokinetic model
    </H1><DIV class="container-fluid" style="background-color: white; box-shadow: 0px 0px 4px rgba(0,0,0,0.56); border-radius: 5px; margin-top: 200px; padding-bottom: 50px"><DIV style="text-align: center; margin-top: 50px; padding-bottom: 20px"><H1 style="font-family:'Impact'; color: #337ab7; border-bottom: 0.8px solid #337ab7; padding-bottom: 20px">Assessment of RVG aptitude</H1></DIV><DIV class="row"><DIV class="col-xs-10"><H2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">Background</H2><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 0px; margin-bottom: 20px">
                    The blood brain barrier (BBB) is formed by¬†many components including endothelial cells of the capillary wall, astrocyte and pericytes. It is the largest interface between the blood and the central nervous system and is situated between the blood and the interstitial fluid. Our RVG construct is designed to steer exosome to cross the obstacle
                    Delivering exosome through BBB is an extremely complex process.
                    The affinity of RVG to nicotinic acetylcholine receptor (nAchR) is critical to clathrin and caveolae-mediated transcytosis,
                    which is the main mechanism of guiding exosome through the barrier. To study the ability of our engineered exosomes to pass the BBB,
                    we simplify the whole process into passing endothelial cells and study the aptitude of RVG¬†by modeling the binding properties to the receptor side of the endothelial cell membrane.
                </P><P style="font-size: 17px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    CX43, a family member of gap junction proteins,
                    can only help us to deliver exosome if it is open and exchange fusion signal with neuron cell. Here,
                    we present a model demonstrating a macroscopic situation in gap junctions,
                    and thereby ensuring the functionality of CX43 as a cytosolic delivery helper.
                </P></DIV></DIV><DIV class="row"><DIV class="col-xs-10"><H2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">Assumption</H2><P style="font-size: 16px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px"><STRONG>1. Interacting bonding rupture does not occur during cellular trafficking of endothelial cell, so transcytosis is successful once endocytosis happens </STRONG><STRONG>2. Influences of hyperaemia are neglected.</STRONG><STRONG>3. endosome can be considered as spheres.</STRONG><STRONG>4. Influences resulting from PH„ÄÅ enzyme and salt concentration in blood are neglected.</STRONG></P></DIV></DIV><DIV style="text-align: center; margin-top: 50px; padding-bottom: 20px"><H1 style="font-family:'Impact'; color: #337ab7; border-bottom: 0.8px solid #337ab7; padding-bottom: 20px">Process and Result</H1></DIV><DIV class="row"><DIV class="col-xs-10"><P style="font-size: 16px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                   The binding of the ligands on the surface of exosomes to the receptors of endothelial cells of capillary wall is affected by the blood flow.
                    Blood flow creates a shearing force at the vessel walls that strains the receptor-ligand bondings and therefore increases the chances of disrupting the interaction. 
                    The following equations are given to measure dislodging force, including drag force (Fd) in the direction of blood flow and a rotating force called the torque (T).
                    The two major forces hinder our exosome  to be bound and thus transported through the endothelial cell.
                </P></DIV></DIV><DIV class="container-fluid row" style="margin-bottom: 50px"><DIV class="col-md-5" style="text-align: center"><P style="text-align: center"><STRONG>Figure 1Ôºödrag force(Fd)</STRONG></P></DIV><DIV class="col-md-5" style="text-align: center"><P style="text-align: center"><STRONG>Figure 2ÔºöRotation force(T)</STRONG></P></DIV></DIV><DIV class="container-fluid row" style="margin-bottom: 50px"><DIV class="col-md-10" style="text-align: center"><P style="font-size: 16px; text-align: justify; font-weight: normal;">
                    The whole forces caused by blood flow could be measured by
                    <SPAN style="font-style: italic"><STRONG>F<SUB>dis</SUB> = Fd + Tq/2</STRONG></SPAN> [11].
                </P><P style="font-size: 16px; text-align: justify; font-weight: normal;">
                    The dislodging force (Fdis) to different size of nanoparticle is then tested.
                </P></DIV></DIV><DIV class="container-fluid row" style="margin-bottom: 0px"><DIV class="col-md-10" style="text-align: center"><P style="font-size: 16px; text-align: justify; font-weight: normal;">
                    There have been studies showing that exosome with 60nm diameter is most suitable for passing the vivo BBB model [11].
                    So Fdis of 10<SUP>-14</SUP> could be used as the force acting on exosome.
                    The probability of forming the interaction and breaking the interaction under shear flow can be given as:
                </P></DIV></DIV><DIV class="container-fluid row" style="margin-bottom: 0px"><DIV class="col-md-10" style="text-align: center"><P style="font-size: 16px; text-align: justify; font-weight: normal;"><STRONG>P<SUB>bonds</SUB>=P<SUB>form</SUB>-P<SUB>break</SUB></STRONG></P><P style="font-size: 16px; text-align: justify; font-weight: normal;">
                    P<SUB>bonds</SUB> represents the steady bonds forming during ligand - receptor contact.
                    We set 10 matching receptor-ligand pairs with a series of association constants for one exosome to test the binding status of 0.5s when it comes to exosome-endothelial contact.
                    If RVG-carried exosome has higher affinity,
                    in other words, transcytosis ability than non-RVG exosome, it should adhere to endothelial cell membrane with more steady interaction.
                </P></DIV></DIV><DIV class="container-fluid row" style="margin-bottom: 15px"><DIV class="col-md-10" style="text-align: center"><P style="font-size: 16px; text-align: justify; font-weight: normal;">
                    Figure: RVG-carried exosome has the better binding ability under different association constant.
                    Extra steady bonds are always formed on engineered exosome,
                    which increases the probability of successful transcytosis and theoretically proves the aptitude of RVG-carried exosomes to across BBB by receptor-mediated transcytosis.
                    Furthermore, more blood-injected exosome will enter into brain than the rest of the body due to the brain-guiding efficiency of RVG.
                </P></DIV></DIV><DIV class="row"><DIV class="col-xs-10"><TABLE class="table" style="border-right: 1px solid rgba(0,0,0,0.1); border-left: 1px solid rgba(0,0,0,0.1); border-bottom: 1px solid rgba(0,0,0,0.1)"><TBODY><TR><TH>Parameters</TH><TH>Definitions</TH><TH>Value</TH><TH>Units</TH><TH>Note</TH></TR><TR><TH style="font-weight: 400">R<SUB>d</SUB></TH><TH style="font-weight: 400">Receptor-ligand density for exosome/RVG-carried exosome</TH><TH style="font-weight: 400">10<SUP>5</SUP>/2X10<SUP>5</SUP></TH><TH style="font-weight: 400">nm<SUP>-2</SUP></TH><TH style="font-weight: 400">[11]</TH></TR><TR><TH style="font-weight: 400">A<SUB>c</SUB></TH><TH style="font-weight: 400">The interfacial contact surface area</TH><TH style="font-weight: 400">225</TH><TH style="font-weight: 400">nm<SUP>2</SUP></TH><TH style="font-weight: 400">Estimated from most-fit exosome</TH></TR><TR><TH style="font-weight: 400">L<SUB>D</SUB></TH><TH style="font-weight: 400">ligand density</TH><TH style="font-weight: 400">10<SUP>5</SUP></TH><TH style="font-weight: 400">nm<SUP>2</SUP></TH></TR><TR><TH style="font-weight: 400">l</TH><TH style="font-weight: 400">distance from the particle center of mass to the cell membrane</TH><TH style="font-weight: 400">35.8</TH><TH style="font-weight: 400">nm</TH></TR><TR><TH style="font-weight: 400">ùë∫ùùÅ</TH><TH style="font-weight: 400">wall shear stress</TH><TH style="font-weight: 400">0.25</TH><TH style="font-weight: 400">Pa</TH><TH style="font-weight: 400">[11]</TH></TR><TR><TH style="font-weight: 400">ùú∏</TH><TH style="font-weight: 400">particle aspect ratio</TH><TH style="font-weight: 400">1</TH></TR><TR><TH style="font-weight: 400">kB</TH><TH style="font-weight: 400">Boltzmann constant</TH><TH style="font-weight: 400">1.0X10<SUP>-3</SUP></TH><TH style="font-weight: 400">min<SUP>-1</SUP></TH></TR><TR><TH style="font-weight: 400">T</TH><TH style="font-weight: 400">temperature</TH><TH style="font-weight: 400">310.15</TH><TH style="font-weight: 400">K</TH></TR><TR><TH style="font-weight: 400">BN</TH><TH style="font-weight: 400">nanoparticle shared over the number of bonds</TH><TH style="font-weight: 400">5</TH></TR><TR><TH style="font-weight: 400">k0/a</TH><TH style="font-weight: 400">the association constant at zero load per receptor-ligand pair</TH><TH style="font-weight: 400">1000/2000/3000/4000</TH><TH style="font-weight: 400">Tested value</TH></TR><TR><TH style="font-weight: 400">kD</TH><TH style="font-weight: 400">dissociation constant</TH><TH style="font-weight: 400">10<SUP>-6</SUP></TH></TR><TR><TH style="font-weight: 400">B<SUB>RL</SUB></TH><TH style="font-weight: 400">bond length</TH><TH style="font-weight: 400">7.2</TH><TH style="font-weight: 400">nm</TH><TH style="font-weight: 400">Estimated from most-fit exosome</TH></TR><TR><TH style="font-weight: 400">ùúπeq</TH><TH style="font-weight: 400">closest distance of the nanoparticle relative to the cell</TH><TH style="font-weight: 400">5.8</TH><TH style="font-weight: 400">nm</TH><TH style="font-weight: 400">[11]</TH></TR><TR><TH style="font-weight: 400">r</TH><TH style="font-weight: 400">Radius of exosome</TH><TH style="font-weight: 400">30</TH><TH style="font-weight: 400">nm</TH><TH style="font-weight: 400">Estimated from most-fit exosome</TH></TR></TBODY></TABLE></DIV></DIV><DIV class="row"><DIV class="col-xs-8"><TABLE class="table" style="border-right: 1px solid rgba(0,0,0,0.1); border-left: 1px solid rgba(0,0,0,0.1); border-bottom: 1px solid rgba(0,0,0,0.1)"><TBODY><TR><TH>Variables</TH><TH>Meaning</TH></TR><TR><TH style="font-weight: 400">P<SUB>a</SUB></TH><TH style="font-weight: 400">The probability of a spherical nanoparticle adhering to the cell membrane</TH></TR><TR><TH style="font-weight: 400">F<SUB>D</SUB></TH><TH style="font-weight: 400">Drag force generated by the blood flow</TH></TR><TR><TH style="font-weight: 400">F<SUB>s</SUB></TH><TH style="font-weight: 400">is the force as a function of aspect ratio</TH></TR><TR><TH style="font-weight: 400">T<SUB>s</SUB></TH><TH style="font-weight: 400">the torque force as a function of aspect ratio</TH></TR><TR><TH style="font-weight: 400">F<SUB>RL</SUB></TH><TH style="font-weight: 400">dislodging force per receptor ligand pair</TH></TR><TR><TH style="font-weight: 400">Tq</TH><TH style="font-weight: 400">Torque</TH></TR><TR><TH style="font-weight: 400">P<SUB>bonds</SUB></TH><TH style="font-weight: 400">The probability to form a stable ligand-receptor bond</TH></TR><TR><TH style="font-weight: 400"><STRONG>Fdis</STRONG></TH><TH style="font-weight: 400"><STRONG>The total dissociating force</STRONG></TH></TR></TBODY></TABLE></DIV></DIV><DIV style="text-align: center; margin-top: 50px; padding-bottom: 20px"><H1 style="font-family:'Impact'; color: #337ab7; border-bottom: 0.8px solid #337ab7; padding-bottom: 20px">
                Simulation of exosome in blood simulation
            </H1></DIV><DIV class="row"><DIV class="col-xs-10"><H2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">Background</H2><P style="font-size: 16px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    Circulation of the blood is a vital function in human body.
                    The main significance of blood circulation is to guarantee a proper metabolism of every cell in the body.
                    The various tissues of the body get various nutrientsÔºå water and oxygen from the blood.
                    Exosome is transported without exception.
                    However, injecting the exosomes into the vein is an efficient but risky approach of delivering exosome to the brain.
                    Excess exosomes in the blood or other parts of the body can be harmful.
                    To ensure a proper delivery of exosome,
                    a pharmacokinetic model is built to simulate the kinetics of exosome circulation in blood after injection.
                </P></DIV></DIV><DIV class="row"><DIV class="col-xs-10"><H2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">Process</H2><P style="font-size: 16px; text-align: justify; font-weight: normal; margin-top: 20px; margin-bottom: 20px">
                    The formulation is connected with two pharmacokinetic ideas.
                    Firstly, Exosome can be reversibly bounded with blood components, which repress them to enter into main parts of body.
                    Also, Heart acts like a pump which determines the proportion and flow of blood to the body by blood circulation.
                    After considering the two basic ideas above, the following formulas are produced.
                </P></DIV></DIV><DIV class="row" style="margin-top: 50px"><DIV class="col-xs-10"><TABLE class="table" style="border-right: 1px solid rgba(0,0,0,0.1); border-left: 1px solid rgba(0,0,0,0.1); border-bottom: 1px solid rgba(0,0,0,0.1)"><TBODY><TR><TH>Parameters</TH><TH>Definitions</TH><TH>Value</TH><TH>Units</TH><TH>Note</TH></TR><TR><TH style="font-weight: 400">k<SUB>blooddis</SUB></TH><TH style="font-weight: 400">Exosomes dissociation from blood components</TH><TH style="font-weight: 400">1.7X10<SUP>-4</SUP></TH><TH style="font-weight: 400">min<SUP>-1</SUP></TH><TH style="font-weight: 400">IGEM NJU 2017</TH></TR><TR><TH style="font-weight: 400">k<SUB>bloodbind</SUB></TH><TH style="font-weight: 400">Exosomes binding to blood components</TH><TH style="font-weight: 400">1.0X10<SUP>-6</SUP></TH><TH style="font-weight: 400">min<SUP>-1</SUP></TH><TH style="font-weight: 400">IGEM NJU 2017</TH></TR><TR><TH style="font-weight: 400">k<SUB>intbrain</SUB></TH><TH style="font-weight: 400">Effective fraction of dose available to brain</TH><TH style="font-weight: 400">0.23</TH><TH style="font-weight: 400">min<SUP>-1</SUP></TH></TR><TR><TH style="font-weight: 400">k<SUB>intheart</SUB></TH><TH style="font-weight: 400">Effective fraction of dose available to heart</TH><TH style="font-weight: 400">1.0X10<SUP>-2</SUP></TH><TH style="font-weight: 400">min<SUP>-1</SUP></TH><TH style="font-weight: 400">IGEM NJU 2017</TH></TR><TR><TH style="font-weight: 400">k<SUB>intliver</SUB></TH><TH style="font-weight: 400">Effective fraction of dose available to liver</TH><TH style="font-weight: 400">1.0X10<SUP>-2</SUP></TH><TH style="font-weight: 400">min<SUP>-1</SUP></TH><TH style="font-weight: 400">IGEM NJU 2017</TH></TR><TR><TH style="font-weight: 400">k<SUB>spleen</SUB></TH><TH style="font-weight: 400">Effective fraction of dose available to spleen</TH><TH style="font-weight: 400">1.0X10<SUP>-3</SUP></TH><TH style="font-weight: 400">min<SUP>-1</SUP></TH><TH style="font-weight: 400">IGEM NJU 2017</TH></TR><TR><TH style="font-weight: 400">k<SUB>lung</SUB></TH><TH style="font-weight: 400">Effective fraction of dose available to lung</TH><TH style="font-weight: 400">1.0X10<SUP>-3</SUP></TH><TH style="font-weight: 400">min<SUP>-1</SUP></TH><TH style="font-weight: 400">IGEM NJU 2017</TH></TR><TR><TH style="font-weight: 400">k<SUB>kidney</SUB></TH><TH style="font-weight: 400">Effective fraction of dose available to kidney</TH><TH style="font-weight: 400">1.0X10<SUP>-2</SUP></TH><TH style="font-weight: 400">min<SUP>-1</SUP></TH><TH style="font-weight: 400">IGEM NJU 2017</TH></TR><TR><TH style="font-weight: 400">k<SUB>adipocyte</SUB></TH><TH style="font-weight: 400">Effective fraction of dose available to adipocyte</TH><TH style="font-weight: 400">1.0X10<SUP>-2</SUP></TH><TH style="font-weight: 400">min<SUP>-1</SUP></TH><TH style="font-weight: 400">IGEM NJU 2017</TH></TR><TR><TH style="font-weight: 400">k<SUB>bbb</SUB></TH><TH style="font-weight: 400">Effective fraction of dose cross the blood brain barrier</TH><TH style="font-weight: 400">0.4</TH><TH style="font-weight: 400">min<SUP>-1</SUP></TH></TR><TR><TH style="font-weight: 400">Q<SUB>c</SUB></TH><TH style="font-weight: 400">Cardiac Output</TH><TH style="font-weight: 400">5.6</TH><TH style="font-weight: 400">L/min</TH><TH style="font-weight: 400">IGEM Slovenia 2012</TH></TR><TR><TH style="font-weight: 400">Q<SUB>heart</SUB></TH><TH style="font-weight: 400">Blood following through heart tissue</TH><TH style="font-weight: 400">5.6</TH><TH style="font-weight: 400">L/min</TH><TH style="font-weight: 400">IGEM Slovenia 2012</TH></TR><TR><TH style="font-weight: 400">Q<SUB>spleen</SUB></TH><TH style="font-weight: 400">Blood following through spleen tissue</TH><TH style="font-weight: 400">0.6</TH><TH style="font-weight: 400">L/min</TH><TH style="font-weight: 400">IGEM Slovenia 2012</TH></TR><TR><TH style="font-weight: 400">Q<SUB>lung</SUB></TH><TH style="font-weight: 400">Blood following through lung tissue</TH><TH style="font-weight: 400">5.6</TH><TH style="font-weight: 400">L/min</TH><TH style="font-weight: 400">IGEM Slovenia 2012</TH></TR><TR><TH style="font-weight: 400">Q<SUB>kidney</SUB></TH><TH style="font-weight: 400">Blood following through heart tissue</TH><TH style="font-weight: 400">1.7</TH><TH style="font-weight: 400">L/min</TH><TH style="font-weight: 400">IGEM Slovenia 2012</TH></TR><TR><TH style="font-weight: 400">Q<SUB>adi</SUB></TH><TH style="font-weight: 400">Blood following through adipose tissue</TH><TH style="font-weight: 400">2.8</TH><TH style="font-weight: 400">L/min</TH><TH style="font-weight: 400">IGEM Slovenia 2012</TH></TR><TR><TH style="font-weight: 400">Q<SUB>liver</SUB></TH><TH style="font-weight: 400">Blood following through liver tissue</TH><TH style="font-weight: 400">1.4</TH><TH style="font-weight: 400">L/min</TH><TH style="font-weight: 400">IGEM Slovenia 2012</TH></TR></TBODY></TABLE></DIV></DIV><DIV class="row"><DIV class="col-xs-8"><TABLE class="table" style="border-right: 1px solid rgba(0,0,0,0.1); border-left: 1px solid rgba(0,0,0,0.1); border-bottom: 1px solid rgba(0,0,0,0.1)"><TBODY><TR><TH>Variables</TH><TH>Determination(Units)</TH></TR><TR><TH style="font-weight: 400">DisExo</TH><TH style="font-weight: 400">Dissociated Exosome in blood(ug)</TH></TR><TR><TH style="font-weight: 400">‚àëE</TH><TH style="font-weight: 400">Sum of exosome entering in tissues except brain(ug)</TH></TR><TR><TH style="font-weight: 400">dFixedExo</TH><TH style="font-weight: 400">Exosome associated with blood component(ug)</TH></TR><TR><TH style="font-weight: 400">dExoB</TH><TH style="font-weight: 400">Exosome after crossing the blood brain barrier(ug)</TH></TR></TBODY></TABLE></DIV></DIV><DIV class="row" style="margin-top: 50px"><DIV class="col-xs-10"><H2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">Results</H2></DIV></DIV><DIV class="row" style="margin-top: 30px"><DIV class="col-xs-6" style="text-align: center"><P style="font-weight: bold; text-align: center; margin-top: 10px">Figure: distribution of injected exosome</P></DIV></DIV><DIV class="row" style="margin-top: 20px"><DIV class="col-xs-10"><P style="font-size: 16px; text-align: justify; font-weight: normal;">
                    According to the figure, most of the injected exosomes are absorbed by brain and other tissues.
                    Those who bind blood components finally go into other parts of body.
                    Also, the sum of exosome (‚àëE) entering into other tissues is approaching the 10% of total injected exosome,
                    which is far less than those entering into the brain (ExoB). This result shows the efficiency of our exosome design.
                    Additionally, the remaining amount of exosome in the blood (DisExo and FixedExo) approach zero within 20 hours.
                </P></DIV></DIV><DIV class="row" style="margin-top: 20px; margin-bottom: 50px"><DIV class="col-xs-10"><H2 style="font-family:'Impact'; color: #337ab7; margin-bottom: 20px">Evaluation</H2><P style="font-size: 16px; text-align: justify; font-weight: normal;">
                    According to our model, RVG could be theoretically helpful to steer exosome on passing BBB.
                    At the meantime,
                    it Increases the proportion of exosomes entering the brain,
                    which lower the risk of causing potential damage to the human body. However,
                    the amount of safe dose of exosome injected into human for curing patient is still remain unknown.
                    
                </P></DIV></DIV></DIV><DIV style="background-color: white; box-shadow: 0px 0px 4px rgba(0,0,0,0.56); border-radius: 5px; margin-top: 50px; background-color: white; padding-bottom: 40px"><DIV style="text-align: center; padding-top: 40px"><H1 style="margin: 0px auto; font-family:'Impact'; color: #337ab7">Collaborators and Supporters</H1></DIV></DIV><DIV class="container-fluid" style="border-top: 1px solid rgba(0,0,0,0.15); height: 240px; padding-top: 30px; background-color: rgb(84,146,197);"><DIV class="row" style="padding: 0px 50px"><DIV class="col-md-4"><DIV><P style="font-size: 26px; font-family:'Open-Sans-L'; color: white;">Location</P></DIV><DIV><P style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">Rm 363, Science Building</P><P style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">Xi'an Jiaotong-Liverpool University</P><P style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">111 Ren'ai Road, Suzhou, China</P><P style="line-height: 16px; font-size: 16px;font-family:'Lato-Light'; color: white;">215123</P></DIV></DIV><DIV class="col-md-4"><DIV><P style="font-size: 26px; font-family:'Open-Sans-L'; color: white;">Social</P></DIV><DIV><P style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">FB</P></DIV></DIV><DIV class="col-md-3"><DIV><P style="font-size: 26px; font-family:'Open-Sans-L'; color: white;">Get in touch</P></DIV><DIV><P style="line-height: 15px; font-size: 16px;font-family:'Lato-Light'; color: white;">igem@xjtlu.edu.cn</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>